RxDoctor Payments Data

Dawn Benefiel, APRN

Acute Care · Toledo, OHNPI 1609392406

Payments from drug & device makers

$2,967in general payments, 2019–2025

Across 149 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$794
  • Sumitomo Pharma America, Inc.$321
  • Johnson & Johnson$270
  • Pfizer$224
  • AbbVie$187
  • Coloplast$168
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$2,45183%
  • Education$51617%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,967 in reported general payments places this provider in the 90th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$108,594
Medicare patients
386
Services billed
3,159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron111$76,408
GemtesaVibegron61$50,731
Fesoterodine Fumarate ErFesoterodine Fumarate90$6,764
Tamsulosin Hcl493$6,599
PremarinEstrogens, Conjugated14$6,123
Tolterodine Tartrate ErTolterodine Tartrate24$2,843
Silodosin74$2,381
Oxybutynin Chloride ErOxybutynin Chloride64$2,123
Finasteride180$1,864
Solifenacin Succinate39$1,773
Alfuzosin Hcl ErAlfuzosin Hcl83$1,739
Dutasteride51$1,275
Trospium Chloride35$1,273
Testosterone Cypionate47$1,085
Bethanechol Chloride26$905

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$794$76,408111 claims
Sumitomo Pharma America, Inc.Gemtesa$321$50,73161 claims
PfizerPremarin$224$6,12314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,101 acute care providers in Ohio.

Other acute care in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →